Stock futures tumble, tax bill failure may make deal unlikely


NEW YORK (Reuters) - Stock futures were sharply lower on Friday, dropping more than 1 percent after a Republican proposal for averting the "fiscal cliff" failed to pass, further eroding optimism that a deal would be reached quickly.


* Late Thursday, Republican House Speaker John Boehner conceded there were insufficient votes from his party to pass a tax bill, dubbed "Plan B," to help avert the cliff, a combination of tax hikes and spending cuts that could send the economy into recession if they take effect next year.


* The plan had called for tax increases on those who earn $1 million a more a year, a far smaller slice of taxpayers than President Barack Obama had asked for.


* The failure seemed to indicate it would be difficult to get Republican support for the more expansive tax increases Obama has asked for, making it less likely an agreement will be reached before the end of the year.


* Investors had previously considered such an outcome unlikely. The decline implied by futures on Friday would wipe out most of the week's equity gains, which took the S&P 500 near two-month highs.


* Banking and energy shares, which outperform in times of economic expansion and have led the market on signs of progress with the fiscal impasse, could be the most vulnerable to any setback. February crude futures dropped 1.3 percent in early trading on Friday.


* S&P 500 futures sank 19 points, or 1.3 percent, and were below fair value, a formula that evaluates pricing by taking into account interest rates, dividends and time to expiration on the contract. Dow Jones industrial average futures lost 184 points and Nasdaq 100 futures slid 36.5 points.


* The S&P is up about 1.8 percent so far this week, boosted as investors took the latest offers from President Barack Obama and Boehner as signs of progress.


* The S&P 500 is up 14.8 percent so far this year, and amid uncertainty from Washington, many traders may lock in their gains as 2012 comes to a close.


* November durable goods data is scheduled for release at 8:30 a.m. (1330 GMT), with the Thomson Reuters/University of Michigan final December consumer sentiment survey due at 9:55.


* Durable goods are seen rising 0.2 percent while the main index in the consumer sentiment survey is seen at 74.7, compared with a prior read of 74.5. On Thursday, strong data on gross domestic product and home sales failed to excite markets as investors focused on the fiscal cliff negotiations.


* Nike Inc late Thursday reported second-quarter earnings that handily beat expectations on strong demand in North America. Software distributor Red Hat Inc posted third-quarter revenue that beat expectations.


* U.S.-listed shares of Research in Motion slumped 10 percent to $12.68 in premarket trading a day after reporting the first ever decline in its subscriber numbers and outlining plans to transform the way it charges for its BlackBerry services.


(Editing by Chizu Nomiyama)



Read More..

AP IMPACT: Big Pharma cashes in on HGH abuse


A federal crackdown on illicit foreign supplies of human growth hormone has failed to stop rampant misuse, and instead has driven record sales of the drug by some of the world's biggest pharmaceutical companies, an Associated Press investigation shows.


The crackdown, which began in 2006, reduced the illegal flow of unregulated supplies from China, India and Mexico.


But since then, Big Pharma has been satisfying the steady desires of U.S. users and abusers, including many who take the drug in the false hope of delaying the effects of aging.


From 2005 to 2011, inflation-adjusted sales of HGH were up 69 percent, according to an AP analysis of pharmaceutical company data collected by the research firm IMS Health. Sales of the average prescription drug rose just 12 percent in that same period.


___


EDITOR'S NOTE — Whether for athletics or age, Americans from teenagers to baby boomers are trying to get an edge by illegally using anabolic steroids and human growth hormone, despite well-documented risks. This is the second of a two-part series.


___


Unlike other prescription drugs, HGH may be prescribed only for specific uses. U.S. sales are limited by law to treat a rare growth defect in children and a handful of uncommon conditions like short bowel syndrome or Prader-Willi syndrome, a congenital disease that causes reduced muscle tone and a lack of hormones in sex glands.


The AP analysis, supplemented by interviews with experts, shows too many sales and too many prescriptions for the number of people known to be suffering from those ailments. At least half of last year's sales likely went to patients not legally allowed to get the drug. And U.S. pharmacies processed nearly double the expected number of prescriptions.


Peddled as an elixir of life capable of turning middle-aged bodies into lean machines, HGH — a synthesized form of the growth hormone made naturally by the human pituitary gland — winds up in the eager hands of affluent, aging users who hope to slow or even reverse the aging process.


Experts say these folks don't need the drug, and may be harmed by it. The supposed fountain-of-youth medicine can cause enlargement of breast tissue, carpal tunnel syndrome and swelling of hands and feet. Ironically, it also can contribute to aging ailments like heart disease and Type 2 diabetes.


Others in the medical establishment also are taking a fat piece of the profits — doctors who fudge prescriptions, as well as pharmacists and distributors who are content to look the other way. HGH also is sold directly without prescriptions, as new-age snake oil, to patients at anti-aging clinics that operate more like automated drug mills.


Years of raids, sports scandals and media attention haven't stopped major drugmakers from selling a whopping $1.4 billion worth of HGH in the U.S. last year. That's more than industry-wide annual gross sales for penicillin or prescription allergy medicine. Anti-aging HGH regimens vary greatly, with a yearly cost typically ranging from $6,000 to $12,000 for three to six self-injections per week.


Across the U.S., the medication is often dispensed through prescriptions based on improper diagnoses, carefully crafted to exploit wiggle room in the law restricting use of HGH, the AP found.


HGH is often promoted on the Internet with the same kind of before-and-after photos found in miracle diet ads, along with wildly hyped claims of rapid muscle growth, loss of fat, greater vigor, and other exaggerated benefits to adults far beyond their physical prime. Sales also are driven by the personal endorsement of celebrities such as actress Suzanne Somers.


Pharmacies that once risked prosecution for using unauthorized, foreign HGH — improperly labeled as raw pharmaceutical ingredients and smuggled across the border — now simply dispense name brands, often for the same banned uses. And usually with impunity.


Eight companies have been granted permission to market HGH by the U.S. Food and Drug Administration, which reviews the benefits and risks of new drug products. By contrast, three companies are approved for the diabetes drug insulin.


The No. 1 maker, Roche subsidiary Genentech, had nearly $400 million in HGH sales in the U.S. last year, up an inflation-adjusted two-thirds from 2005. Pfizer and Eli Lilly were second and third with $300 million and $220 million in sales, respectively, according to IMS Health. Pfizer now gets more revenue from its HGH brand, Genotropin, than from Zoloft, its well-known depression medicine that lost patent protection.


On their face, the numbers make no sense to the recognized hormone doctors known as endocrinologists who provide legitimate HGH treatment to a small number of patients.


Endocrinologists estimate there are fewer than 45,000 U.S. patients who might legitimately take HGH. They would be expected to use roughly 180,000 prescriptions or refills each year, given that typical patients get three months' worth of HGH at a time, according to doctors and distributors.


Yet U.S. pharmacies last year supplied almost twice that much HGH — 340,000 orders — according to AP's analysis of IMS Health data.


While doctors say more than 90 percent of legitimate patients are children with stunted growth, 40 percent of 442 U.S. side-effect cases tied to HGH over the last year involved people age 18 or older, according to an AP analysis of FDA data. The average adult's age in those cases was 53, far beyond the prime age for sports. The oldest patients were in their 80s.


Some of these medical records even give explicit hints of use to combat aging, justifying treatment with reasons like fatigue, bone thinning and "off-label," which means treatment of an unapproved condition. In other cases, the drug was used "for an unknown indication," meaning that the reason for treatment wasn't clear.


Even Medicare, the government health program for older Americans, allowed 22,169 HGH prescriptions in 2010, a five-year increase of 78 percent, according to data released by the Centers for Medicare and Medicaid Services in response to an AP public records request. And nearly half the increase came in one year: 2007.


"There's no question: a lot gets out," said hormone specialist Dr. Mark Molitch of Northwestern University, who helped write medical standards meant to limit HGH treatment to legitimate patients.


And those figures don't include HGH sold directly by doctors without prescriptions at scores of anti-aging medical practices and clinics around the country. Those numbers could only be tallied by drug makers, who have declined to say how many patients they supply and for what conditions.


The AP approached every U.S.-authorized manufacturer to ask what efforts they make to market responsibly and prevent abuse. Only one HGH supplier, Novo Nordisk, agreed to an interview.


"We're doing our level best to make sure that the right patients are getting the right medicine at the right time," said company spokesman Ken Inchausti.


He said the company is aware of the abuse issue. He said if patients apply for assistance from the company's patient-support hub, prescriptions will be flagged for review if they are missing the most rigorous test or an endocrinologist's signature. He said the company won't sell HGH directly to doctors accused of bad practices and does not deal with anti-aging clinics.


Representatives of other FDA-approved HGH makers insist they do not encourage use by bodybuilders or athletes or wealthy baby boomers trying to recapture their youth. But some said they are largely powerless to control who uses their medications or why.


"Lilly cannot restrict the actions of distributors, pharmacies or doctors," Eli Lilly spokeswoman Kelley Murphy said in a written statement.


That argument doesn't fly for critics like Dr. Peter Rost, a retired Pfizer executive who filed a whistleblower lawsuit over the HGH marketing practices of Pharmacia, which later merged with Pfizer. He said drug companies are simply looking the other way and betting that their profits will eclipse the cost of any fines.


They view it as "good business," he said.


___


PEDDLED ON INTERNET


Type "human growth hormone" into any Internet search engine, and it will spit back countless websites with overblown promises of smoother skin, better sex, weight loss and even renewed body organs.


Any doctor who actually prescribes the drug for those purposes is taking a legal risk.


FDA regulations ban the sale of HGH as an anti-aging drug. In fact, since 1990, prescribing it for things like weight loss and strength conditioning has been punishable by 5 to 10 years in prison.


Such marketing claims are routinely made at hormone clinics like Palm Beach Life Extension, whose owners are among 13 people now awaiting trial on federal charges in Florida in a steroids and HGH distribution case brought last year.


"Grow YOUNG with Us!" screamed a banner on the company's now-defunct website, which advertised that HGH can reduce body fat, improve vision, strengthen the immune system, aid kidney function, lower blood pressure and enhance memory and mood.


The clinic arranged to have its clients' prescriptions filled at Treasure Coast Pharmacy, in Jensen Beach, Fla.


In 2009, the FBI recorded a phone call between the pharmacy's owner, Peter Del Toro, and a doctor in Elkton, Md., who was cooperating with agents after being implicated in a related steroid-distribution case.


Their talk, documented in a court filing, illustrates how things often work in the networks of pharmacies and clinics that drive HGH sales.


Patients submitted a medical history form by mail and took a blood test. But in most instances, the indictment said, the evaluation was a sham: One doctor was charged with giving a clinic a pad of blank, signed prescriptions to save him the chore of signing off on each diagnosis. He got $50 for every drug order bearing his name, the indictment said.


Dr. Rodney Baltazar, the Maryland physician cooperating with the FBI, sometimes consulted briefly with patients via webcam. But he made it clear in the call that those evaluations were perfunctory at best.


Baltazar was a gynecologist, not an endocrinologist. He said he knew "a little bit" about HGH and testosterone, which are often prescribed in tandem, but he relied largely on clinic salespeople to set doses.


The pharmacist coached the doctor: Keep detailed medical charts documenting that patients are taking the drug for at least some kind of health problem, just in case the U.S. Drug Enforcement Administration ever came calling.


"Because somebody questions you, you want to be able to say, 'Here, look at his chart. You know, he's got fatigue. He's got, you know, a decreased sex drive. He's got increased body fat. He has some -- some slight depression, probably.' Whatever his signs and symptoms are."


None of these conditions is a legal reason to prescribe HGH. But the pharmacist said that most investigators will be satisfied and move on "because there's guys that are just selling stuff basically like a boiler room."


Del Toro was arrested along with 12 other people in September 2011 on charges that they distributed steroids and human growth hormone to people who had no legitimate medical need. He is awaiting trial. His lawyer declined to comment. Baltazar was sentenced to six months in prison for involvement in steroid distribution schemes.


At the height of the crackdown in 2007, the federal government went after Pfizer in a case involving anti-aging clinics. The company paid $34.7 million in fines to settle the case — 11 percent of the company's annual revenue from the drug.


___


TROUBLED HISTORY


Blockbuster U.S. sales of HGH represent the latest frustration in 25 years of government efforts to control abuse of the growth drug made infamous by sports scandals.


First marketed in 1985 for children with stunted growth, HGH was soon misappropriated by adults intent on exploiting its modest muscle- and bone-building qualities. Congress limited HGH distribution to the handful of rare conditions in an extraordinary 1990 law, overriding the generally unrestricted right of doctors to prescribe medicines as they see fit.


Despite the law, illicit HGH spread around the sports world in the 1990s, making deep inroads into bodybuilding, college athletics, and professional leagues from baseball to cycling. The even larger banned market among older adults has flourished more recently.


For years, cheaper supplies from unauthorized foreign factories, particularly in China, fed the market via direct and Internet sales that sidestepped the medical establishment.


Though such shipments were banned under other law, the imports initially attracted little attention because they were usually labeled as raw pharmaceutical ingredients, which compounding pharmacies are allowed to bring into the country.


That flow began to be curtailed in 2006, when U.S. drug authorities stepped up efforts to block shipments at the border.


A handful of pharmacies across the country were hit with criminal charges over their handling of HGH. Federal prosecutors charged China's biggest HGH maker, GeneScience Pharmaceutical, with illegally distributing its Jintropin brand in the U.S. The company's CEO pleaded guilty in 2010.


With illicit supplies crimped, many pharmacies stopped selling unauthorized HGH. But tens of thousands of adult abusers began buying pricey U.S.-approved HGH that remained available in abundant supply, the AP found in its analysis of sales data.


Thus, pushed by a powerful demand, sales of U.S.-approved brands have swelled far beyond expected levels for a drug approved in just a handful of rare conditions.


Dr. Robert Marcus, a retired hormone specialist who left HGH manufacturer Eli Lilly and Co. in 2008, said that company was bent on stopping foreign counterfeits, not on cutting off abusers. "That's where their major level of frustration was — pharmaceutical fraud — rather than focusing on people who were using growth hormone illegitimately," he said.


Dr. Jim Meehan, of Tulsa, Okla., who has used HGH to treat aging problems and sports injuries, said the federal clampdown "never seemed to affect my patients and their ability to get Omnitrope, Tev-Tropin" and other government-approved brands.


The big drug companies have applauded the foreign crackdown and urged the government to do even more to combat sales of fake or fraudulently labeled HGH. In 2004, Bruce Kuhlik, speaking for the Pharmaceutical Research and Manufacturers of America, told a federal task force that unauthorized drug importation "is inherently unsafe" and industry representatives used Chinese HGH imports as their poster child.


In 2007, as the HGH embargo gained momentum, authorized makers picked up 41 percent more HGH orders, raising their annual total from 245,000 to 345,000, according to the analysis of the IMS Health data. Similarly, most of the drug's sales boom happened in the first two years of the crackdown, with 46 percent inflation-adjusted growth in yearly sales to $1.1 billion.


Steve Kleppe, of Scottsdale, Ariz., a restaurant entrepreneur who has taken HGH for almost 15 years to keep feeling young, said he noticed a price jump of about 25 percent after the block on imports. He now buys HGH directly from a doctor at an annual cost of about $8,000 for himself and the same amount for his wife.


Despite higher prices, the business has expanded in recent years largely on the strength of sales to healthy adults who can afford to indulge their hope of retaining youthful vigor.


___


GROWING OLD


Many older patients go for HGH treatment to scores of anti-aging practices and clinics heavily concentrated in retirement states like Florida, Nevada, Arizona and California.


These sites are affiliated with hundreds of doctors who are rarely endocrinologists. Instead, many tout certification by the American Board of Anti-Aging and Regenerative Medicine, though the medical establishment does not recognize the group's bona fides.


The clinics offer personalized programs of "age management" to business executives, affluent retirees, and other patients of means, sometimes coupled with the amenities of a vacation resort.


The clinics insist there are few, if any, side effects from HGH. Mainstream medical authorities say otherwise.


A 2007 review of 31 medical studies showed swelling in half of HGH patients, with joint pain or diabetes in more than a fifth. A French study of about 7,000 people who took HGH as children found a 30 percent higher risk of death from causes like bone tumors and stroke, stirring a health advisory from U.S. authorities.


For proof that the drug works, marketers turn to images like the memorable one of pot-bellied septuagenarian Dr. Jeffry Life, supposedly transformed into a ripped hulk of himself by his own program available at the upscale Las Vegas-based Cenegenics Elite Health. (He declined to be interviewed.)


These promoters of HGH say there is a connection between the drop-off in growth hormone levels through adulthood and the physical decline that begins in late middle age. Replace the hormone, they say, and the aging process slows.


"It's an easy ruse. People equate hormones with youth," said Dr. Tom Perls, a leading industry critic who does aging research at Boston University. "It's a marketing dream come true."


Some scientific studies of HGH have found modest benefits: some muscle and bone building, as well as limited fat loss, but nothing like the claims of the anti-aging industry. And some of the value credited to HGH may instead come from testosterone, which is routinely provided with HGH by anti-aging doctors and sports suppliers.


Endocrinologists say it's natural for the body to produce less growth hormone as people age beyond their early 20s, because they aren't growing anymore. Only a tiny number of adults with extraordinarily low HGH levels — perhaps several thousand of them — are believed to suffer real deficiencies that can properly be treated with the hormone.


Still, anti-aging doctors routinely diagnose otherwise healthy middle-aged people with an HGH deficiency, simply because their levels are lower than in young adults. "Basically anyone going through midlife," can benefit from the drug, declared one prescriber, Dr. Howard Elkin, of Whittier, Calif., who has himself competed as a bodybuilder.


Dr. Kenneth Knott, of Marietta, Ga., said HGH helps his older patients feel "more vibrant" and look "more alive."


Like many anti-aging doctors, he diagnoses patients by testing for a blood component called insulin growth factor, which is indirectly tied to HGH. Endocrinologists use a more authoritative test that stimulates the pituitary gland to make HGH itself. Nearly all insurers insist on this stimulation testing, and that's why clinic patients almost always pay for HGH out of their own pockets.


Bob Vitols, a 50-year-old lab assistant at a veterinary medicine company in Lincoln, Neb., is a rare exception. His unusually generous health plan isn't allowed to challenge a doctor's prescription.


Four years ago, Vitols began feeling run down. So he Googled his symptoms on the Internet, decided he had a hormone deficiency, and sought out a clinic.


One doctor put him on testosterone replacement therapy. A second clinic added HGH after diagnosing him with osteopenia, a mild bone thinning common in aging adults. It is not, however, a condition that can properly be treated with HGH.


Despite the diagnosis, the treatments — which can cost $10,000 per year — have been covered by his health insurance, he said. He takes Genotropin, the HGH made by Pfizer. His prescriptions are filled via mail order by CVS Caremark Corp., one of the largest dispensers of prescription drugs in the U.S.


Vitols said the drug changed his life: his mood is better, and he isn't burning out every day at 2 p.m. "I feel like I could walk outside and just walk through a fence — and come out fine on the other side," he said.


His experiences with the drug haven't all been positive, though. Vitols said he initially developed elevated liver enzymes and went to a specialist, who told him to stop taking hormones immediately.


Instead, Vitols said, he adjusted his dosage, and the problem disappeared.


He also dumped the specialist:


"I could tell he was against hormones right at the start," Vitols said.


___


Associated Press Writer David Caruso reported from New York and AP National Writer Jeff Donn reported from Plymouth, Mass. AP Writer Troy Thibodeaux provided data analysis assistance from New Orleans.


___


AP's interactive on the HGH investigation: http://hosted.ap.org/interactives/2012/hgh


___


The AP National Investigative Team can be reached at investigate(at)ap.org


EDITOR'S NOTE _ Whether for athletics or age, Americans from teenagers to baby boomers are trying to get an edge by illegally using anabolic steroids and human growth hormone, despite well-documented risks. This is the second of a two-part series.


Read More..

On gun control, look to Biden




Rebecca Puckwalter-Poza says Vice President Joe Biden was a leader on gun control in the Senate.




STORY HIGHLIGHTS


  • Rebecca Buckwalter-Poza: Obama has apparently tapped Biden as gun control point man

  • She says he was leader in Senate on issue, shepherding 1994 gun control legislation

  • It banned manufacture of many semi-automatic guns,criminalized high-capacity magazines

  • Writer: Biden worked across aisle; he's adroit, determined statesman, right man for job




Editor's note: Rebecca Buckwalter-Poza served as deputy national press secretary of the Democratic National Committee during the 2008 election.


(CNN) -- President Obama's poignant speech at Sunday's interfaith vigil in Newtown, Connecticut, set the tone for our mourning. Now, America's path forward will be decided out of the spotlight. The question of whether the tragedy at Sandy Hook Elementary School will linger only in memory or be memorialized by an enduring shift in gun policy can only be answered by the legislature.


Incoming Judiciary Committee chair Sen. Diane Feinstein has announced she will introduce an enhanced assault weapons ban on the first day of the new Congress, but the fate of that legislation is in the hands of Vice President Joe Biden.


Biden will reportedly lead the administration's political response.



Rebecca Buckwalter-Poza

Rebecca Buckwalter-Poza



No politician could be better suited to the challenge of passing federal gun control legislation than Biden. Over the past four decades, Biden has been one of the most consistent and effective advocates of gun control and violence prevention legislation. In 1994, Biden shepherded the Violent Crime Control and Law Enforcement Act through the Senate, a near miracle six years in the making.


After Biden wrote the Violent Crime Control and Law Enforcement Act in 1988, Republicans quickly filibustered, blocking the bill for four years. He steered "the Biden crime bill" through the lengthy filibuster by negotiating with Republicans and making revisions. "Every single line in that bill was written with every single major Republican a part of it," Biden said in a September 12, 1994, interview on the Charlie Rose show.


The Clinton administration and then-Sen. Biden repeatedly refused to make concessions that would have jeopardized the substance of the act, even after debate over the amendment we know as the federal assault weapons ban imperiled the entire bill. Instead of backing down, Biden took on Republican Sens. Phil Gramm and Orrin Hatch and faced opponents attacking the bill as taxpayer-funded "dance lessons and midnight basketball for robbers and rapists."


France: Where fear and taboo control guns more than laws


Biden did not budge: "Make no mistake, this is about guns, guns, guns." The crime bill passed the Senate in November 1993.



When the bill foundered in the House, Biden persevered. It reached President Clinton's desk thanks to an unexpected, eleventh-hour push from a "Lost Battalion of Republicans" led by Rep. Mike Castle of Delaware. He'd been swayed during a series of meetings with the House Speaker and other House Republicans, at which Biden was the only Senator in attendance.


The resulting legislation banned the manufacture of 19 types of semi-automatic firearms and criminalized the possession of high-capacity magazines. The process taught a critical lesson: When otherwise "pro-gun'" lawmakers have to choose between a crime bill including a gun ban and inaction, it is more than possible for them to vote to protect Americans. Unfortunately, the assault weapons ban expired in 2004. Since then, numerous lawmakers, including Joe Biden, have tried and failed to get the ban renewed.


Congress now has a rare opportunity to take new action on gun control. After Newtown, proponents of stricter gun legislation are backed by public opinion and bolstered by a surge of political support. The "pro-gun" wing of the GOP and the National Rifle Association remain silent even as their supporters are defecting publicly.


Democratic Sens. Harry Reid and Joe Manchin, whose voting record earned them the NRA's "top rating," have backed off their "pro-gun" positions and declared that "everything must be on the table" for legislative debate. The 31 pro-gun senators have not spoken since Friday's tragedy, signaling the possibility that some of them might be changing their minds on guns, too.


Lawmakers are essentially being asked to consider an updated version of the 1994 assault weapons ban. On Sunday, Feinstein promised the legislation "will ban the sale, the transfer, the importation and the possession" of assault weapons and ban high-capacity magazines as well as "clips of more than ten bullets."












Biden will likely support a new ban on assault weapons and push for improvements. His 2007 Crime Control and Prevention Act would not only have renewed the ban but required background checks for all gun purchases, closing the "gun show loophole.'" Biden has also called on Congress to address the relationship of mental illness to violence in the wake of the Virginia Tech shootings.


Was your gun banned?


The president cautioned Americans Sunday, saying "no single law, no set of laws can eliminate evil from the world, or prevent every senseless act of violence in our society. But that can't be an excuse for inaction. Surely, we can do better than this."


In his first term, however, Obama practiced a policy of appeasement, failing to block the expansion of gun rights or promote gun control. To ensure Congress passes tough, comprehensive gun control laws rather than settling for a watered-down version, as with health care, Obama must let Biden lead.


Why? Biden has distinguished himself as an adroit and effective statesman in both the legislative and the executive branches. The former six-term senator has a deft touch with moderate and conservative counterparts: in 2008, he eulogized Strom Thurmond. As vice president, he has spearheaded the implementation of the American Recovery and Reinvestment Act. Moreover, Biden has a particular passion for protecting students and educators. His wife, Jill Biden, has been teaching for more than 30 years.


The deaths of 20 first-graders and six adults compel all Americans as sons and daughters, fathers and mothers, uncles and aunts, to consult their moral compasses. Legislators face a greater responsibility: a moral imperative to pass any legislation that could possibly prevent a future Newtown, Aurora, Oak Creek or Blacksburg.


Opinion: Gun violence is a national security issue


As Obama ministers to the American people and offers words of comfort, Biden must move lawmakers to action. In 1994, Biden warned his colleagues, "we simply can't let the gun lobby deny to the American people the vital benefits in this bill." Biden must once more appeal to Congress to enact gun control. If anyone can succeed in those chambers, it's Joe Biden.


Follow us on Twitter @CNNOpinion.


Join us on Facebook/CNNOpinion.


The opinions expressed in this commentary are solely those of Rebecca Buckwalter-Poza






Read More..

Why “Les Misérables” Looks Like a Holiday Box-Office Smash






LOS ANGELES (TheWrap.com) – Moviegoers are storming online ticketing sites in advance of the Christmas release of “Les Misérables,” and the big-screen adaptation of the Broadway musical has all the makings of a holiday smash.


With a cast that includes Anne Hathaway and Hugh Jackman, expectations are enormous, but based on advance tracking, so is the box-office potential.






The film, made for a reported $ 61 million, is poised to gross as much as $ 26 million over its opening weekend, according to BoxOffice.com.


The site predicts that the movie should pick up multiple Oscar nominations and that awards attention combined with a rabid fan base of musical theater lovers will have it beguiling moviegoers well into the new year.


Ultimately, it estimates that “Les Misérables” will rack up as much as $ 136 million at the domestic box office.


It’s well on its way. Early ticket sales at Fandango indicate that “Les Misérables” has the potential to be this holiday’s breakout smash, despite stiff competition from the likes of Tom Cruise’s “Jack Reacher” and Quentin Tarantino’s “Django Unchained,” both of which open over the next seven days.


Fandango also reports that the film has smashed records to become the company’s top advance-ticket seller among all Christmas Day releases, surpassing its previous record-holder, 2009′s “Sherlock Holmes”


It is also the largest advance-ticket seller among movie musicals in its history, supplanting 2006′s “Dreamgirls.” By mid-day Wednesday, “Les Misérables” was outpacing all other films, even current releases like “The Hobbit: An Unexpected Journey,” and was responsible for 40 percent of ticket sales at Fandango.


“There’s such a history and good will surrounding the stage musical and this is a film version people have been anticipating for such a long time, that it has turned into the movie event of the holiday season,” Dave Karger, Fandango’s chief correspondent, told TheWrap.


“We’re bullish on it,” added Phil Contrino, editor of BoxOffice.com. “Based on all the early reviews, this sounds like a crowd-pleaser. When a musical hits, it becomes a beast at the box office.”


He noted that “Mamma Mia!,” which arrived with less awards pedigree and was derived from a more dimly known stage show, grossed $ 609.8 million globally, because audiences loved the music.


Movietickets.com did not release any pre-sales information for holiday releases. However, recent surveys it performed of more than 4,000 customers indicate that there is a great deal of enthusiasm for the musical.


Of the major holiday releases, 52 percent of those polled said they were most excited to see “Les Misérables.” That was followed by 24 percent for “Django Unchained,” 16.5 percent for “Jack Reacher” and 7.5 percent for “The Guilt Trip.”


To be sure, not all of the “Les Misérables” reviews have been kind. In TheWrap, Alonso Duralde faulted the wobbly vocal talents of the leads and the director’s penchant for close-ups of his emoting stars.


“Director Tom Hooper (‘The King’s Speech’) piles one terrible decision upon another, with the result being a movie so overbearingly maudlin and distorted that it’s one of 2012′s most excruciating film experiences,” Duralde wrote.


Yet, audiences at screenings have been nearly rapturous in their response. Fandango’s Karger notes that at a recent screening for members of the Academy of Motion Picture Arts and Sciences that he attended, the crowd broke into applause at four different points during the film and gave Jackman and Hooper lusty ovations.


Given that “Les Misérables” tackles such topics as revolution, poverty and prostitution it seems like dark fare for the season, but Karger argues that the film provides enough uplift to appeal to moviegoers looking to get into the yuletide spirit.


“There are scenes of such intense suffering and despair in the movie, but at the end you are left with a profound feeling of love and that gives it a holiday feel,” Karger said. “It’s a slog through the mud to get there, but when the movie’s over you leave the theater with a wonderful sense of hope.”


If Karger is right then Universal, which is distributing “Les Misérables,” will be feeling very festive when Christmas rolls around next week.


Movies News Headlines – Yahoo! News





Title Post: Why “Les Misérables” Looks Like a Holiday Box-Office Smash
Rating:
100%

based on 99998 ratings.
5 user reviews.
Author: Fluser SeoLink
Thanks for visiting the blog, If any criticism and suggestions please leave a comment




Read More..

UK retail sales flat in November







UK retail sales failed to grow in November, adding to fears that consumers are reining in spending ahead of Christmas.






Sales volumes were flat in November compared with October, the Office for National Statistics (ONS) said.


They had been expected to bounce back after October’s shock 0.8% fall.


The one bright spot was in household goods stores, where sales rose by 3.8% on the month, including consumer electrical items.


However this failed to offset a 0.1% drop in both food sales and sales of clothes and shoes.


Year-on-year, sales volumes rose by 0.9%.


‘Last-minute rush’


By value, sales fell 0.1% on the month but increased 1.5% on the year.


Consumer spending accounts for about two-thirds of gross domestic product (GDP) in the UK.


The ONS figures increase the chance that the UK economy will contract in the last three months of 2012, something the Bank of England has already said is likely.


This year has seen a number of casualties on the High Street, the latest being electrical retailer Comet, whose last stores closed this week.


British Retail Consortium director-general Helen Dickinson, said that the coming weekend would be crucial for retailers.


“With Christmas falling on a Tuesday this year, this weekend will be the critical one – I’m expecting a last-minute rush but overall in sales terms it will be neither a bumper Christmas nor a disaster.”


BBC News – Business





Title Post: UK retail sales flat in November
Rating:
100%

based on 99998 ratings.
5 user reviews.
Author: Fluser SeoLink
Thanks for visiting the blog, If any criticism and suggestions please leave a comment




Read More..

Bankrate: Mortgage Rates Jump on News of Fed Stimulus






NEW YORK, Dec. 20, 2012 /PRNewswire/ – Mortgage rates posted the biggest one week increase since March, with the benchmark 30-year fixed mortgage rate jumping from 3.52 percent to 3.62 percent, according to Bankrate.com’s weekly national survey. The average 30-year fixed mortgage has an average of 0.31 discount and origination points.


(Logo: http://photos.prnewswire.com/prnh/20040122/FLTHLOGO)






To see mortgage rates in your area, go to http://www.bankrate.com/funnel/mortgages/.


The average 15-year fixed mortgage rate was up more modestly to 2.89 percent and the larger jumbo 30-year mortgage climbed back over the 4 percent threshold to 4.07 percent. Adjustable rate mortgages were mostly higher, with the 3-year ARM moving to 2.93 percent and the 5-year ARM now at 2.78 percent, both the highest since August.


Mortgage rates posted these sudden increases following last week’s announcement of additional stimulus by the Federal Reserve. While this newly announced bond-buying program is designed to keep long-term interest rates and mortgage rates low, the initial reaction was opposite because of concerns that the Fed’s printing of more money would eventually lead to higher inflation. Not to worry, however, as the fiscal cliff issue is still at center stage and as year-end draws closer without an agreement, that is likely to push bond yields and mortgage rates back down.


The last time mortgage rates were above 6 percent was Nov. 2008. At the time, the average 30-year fixed rate was 6.33 percent, meaning a $ 200,000 loan would have carried a monthly payment of $ 1,241.86. With the average rate now 3.62 percent, the monthly payment for the same size loan would be $ 911.54, a difference of $ 330 per month for anyone refinancing now.


SURVEY RESULTS


30-year fixed: 3.62% — up from 3.52% last week (avg. points: 0.31)


15-year fixed: 2.89% — up from 2.85% last week (avg. points: 0.24)


5/1 ARM: 2.78% — up from 2.74% last week (avg. points: 0.27)


Bankrate’s national weekly mortgage survey is conducted each Wednesday from data provided by the top 10 banks and thrifts in the top 10 markets.


For a full analysis of this week’s move in mortgage rates, go to http://www.bankrate.com.


The survey is complemented by Bankrate’s weekly Rate Trend Index, in which a panel of mortgage experts predicts which way the rates are headed over the next seven days. Two-thirds of panelists, 67 percent, see mortgage rates increasing further over the coming week. One quarter expect mortgage rates to remain more or less unchanged and just 8 percent forecast a decline in the next seven days.


About Bankrate, Inc. (RATE)
The Bankrate network of companies includes Bankrate.com, Interest.com, Mortgage-calc.com, Nationwide Card Services, InsureMe, CreditCardGuide.com, Bankaholic, CreditCards.com and NetQuote.  Each of these businesses helps consumers to make informed decisions about their personal finance matters. The company’s flagship brand, Bankrate.com is a destination site of personal finance channels, including banking, investing, taxes, debt management and college finance. Bankrate.com is the leading aggregator of rates and other information on more than 300 financial products, including mortgages, credit cards, new and used auto loans, money market accounts and CDs, checking and ATM fees, home equity loans and online banking fees. Bankrate.com reviews more than 4,800 financial institutions in 575 markets in 50 states. Bankrate.com provides financial applications and information to a network of more than 75 partners, including Yahoo! (YHOO), America Online (AOL), The Wall Street Journal and The New York Times (NYT). Bankrate.com’s information is also distributed through more than 500 newspapers.


For more information contact:
Kayleen Yates
Senior Director, Corporate Communications
[email protected]
(917) 368-8677


Yahoo! Finance – Personal Finance | Loans





Title Post: Bankrate: Mortgage Rates Jump on News of Fed Stimulus
Rating:
100%

based on 99998 ratings.
5 user reviews.
Author: Fluser SeoLink
Thanks for visiting the blog, If any criticism and suggestions please leave a comment




Read More..

Stock futures flat on uncertainty over "fiscal cliff" talks


NEW YORK (Reuters) - Stock index futures were flat on Thursday amid uncertainty over U.S. fiscal negotiations, as President Barack Obama threatened to veto a controversial Republican plan, suggesting a deal wouldn't come as soon as many investors had hoped.


Republican Speaker of the House John Boehner, in a brief press conference Wednesday, said his chamber would pass a proposal that spares many wealthy Americans from tax hikes needed to balance the budget. Obama has threatened to veto the plan if it passes, while some Republicans oppose any deal featuring tax increases.


"This is enough to make people think talks have regressed, which is making people nervous," said James Dailey, portfolio manager of TEAM Asset Strategy Fund in Harrisburg, Pennsylvania. "We don't know how much of this is just political posturing, and we're probably past the point of automatic faith a deal will be cut."


Equities have been volatile this week, though they notched strong gains Monday and Tuesday as offers from Obama and Boehner indicated progress was being made in budget discussions.


That rally ended Wednesday as shares slumped, though they remain near a two-month high, as a rise in tensions in the talks threatened to unravel recent progress.


While many investors still expect a deal to avert the "fiscal cliff," steep tax hikes and spending cuts due to take effect in 2013 that could tip the economy into recession, agreement may not come as quickly as they had hoped.


S&P 500 futures rose 1.2 point and were above fair value, a formula that evaluates pricing by taking into account interest rates, dividends and time to expiration on the contract. Dow Jones industrial average futures added 9 point and Nasdaq 100 futures rose 5.75 points.


Stocks have rallied recently on signs of progress in the negotiations, led by banking and energy shares, which tend to outperform in times of economic expansion. On signs of complications, however, many have turned to hedging their bets through options and exchange-traded funds.


Investors await the latest economic data for trading impetus; weekly jobless claims and the final estimate on third-quarter gross domestic product are both due at 8:30 a.m. ET (1330 GMT). The pace of growth is likely to be revised up to 2.8 percent from 2.7 percent, while claims are expected to rise to 357,000 in the latest week, from 343,000.


November existing home sales are due at 10:00 a.m. and are seen rising 1.3 percent, compared with 2.1 percent in October, while the Philadelphia Federal Reserve Bank's December business activity survey is forecast to come in at -3.0 compared to -10.7 in November.


"People are starting to feel vulnerable on the fiscal cliff, so any negative data could have an outsized impact on trading," Dailey said.


IntercontinentalExchange Inc is in talks to buy NYSE Euronext , the operator of the New York Stock Exchange, according to a source familiar with the situation on Wednesday, in a multibillion dollar deal.


Google Inc agreed to sell set-top TV box maker Motorola Home to Arris Group Inc for $2.35 billion in cash and stock. Arris rose 3.2 percent to $15 in premarket trading.


(Editing by Bernadette Baum)



Read More..

AP IMPACT: Steroids loom in major-college football


WASHINGTON (AP) — With steroids easy to buy, testing weak and punishments inconsistent, college football players are packing on significant weight — 30 pounds or more in a single year, sometimes — without drawing much attention from their schools or the NCAA in a sport that earns tens of billions of dollars for teams.


Rules vary so widely that, on any given game day, a team with a strict no-steroid policy can face a team whose players have repeatedly tested positive.


An investigation by The Associated Press — based on dozens of interviews with players, testers, dealers and experts and an analysis of weight records for more than 61,000 players — revealed that while those running the multibillion-dollar sport believe the problem is under control, that is hardly the case.


The sport's near-zero rate of positive steroids tests isn't an accurate gauge among college athletes. Random tests provide weak deterrence and, by design, fail to catch every player using steroids. Colleges also are reluctant to spend money on expensive steroid testing when cheaper ones for drugs like marijuana allow them to say they're doing everything they can to keep drugs out of football.


"It's nothing like what's going on in reality," said Don Catlin, an anti-doping pioneer who spent years conducting the NCAA's laboratory tests at UCLA. He became so frustrated with the college system that it drove him in part to leave the testing industry to focus on anti-doping research.


Catlin said the collegiate system, in which players often are notified days before a test and many schools don't even test for steroids, is designed to not catch dopers. That artificially reduces the numbers of positive tests and keeps schools safe from embarrassing drug scandals.


While other major sports have been beset by revelations of steroid use, college football has operated with barely a whiff of scandal. Between 1996 and 2010 — the era of Barry Bonds, Mark McGwire, Marion Jones and Lance Armstrong — the failure rate for NCAA steroid tests fell even closer to zero from an already low rate of less than 1 percent.


The AP's investigation, drawing upon more than a decade of official rosters from all 120 Football Bowl Subdivision teams, found thousands of players quickly putting on significant weight, even more than their fellow players. The information compiled by the AP included players who appeared for multiple years on the same teams, making it the most comprehensive data available.


For decades, scientific studies have shown that anabolic steroid use leads to an increase in body weight. Weight gain alone doesn't prove steroid use, but very rapid weight gain is one factor that would be deemed suspicious, said Kathy Turpin, senior director of sport drug testing for the National Center for Drug Free Sport, which conducts tests for the NCAA and more than 300 schools.


Yet the NCAA has never studied weight gain or considered it in regard to its steroid testing policies, said Mary Wilfert, the NCAA's associate director of health and safety. She would not speculate on the cause of such rapid weight gain.


The NCAA attributes the decline in positive tests to its year-round drug testing program, combined with anti-drug education and testing conducted by schools.


"The effort has been increasing, and we believe it has driven down use," Wilfert said.


Big gains, data show


The AP's analysis found that, regardless of school, conference and won-loss record, many players gained weight at exceptional rates compared with their fellow athletes and while accounting for their heights. The documented weight gains could not be explained by the amount of money schools spent on weight rooms, trainers and other football expenses.


Adding more than 20 or 25 pounds of lean muscle in a year is nearly impossible through diet and exercise alone, said Dan Benardot, director of the Laboratory for Elite Athlete Performance at Georgia State University.


The AP's analysis corrected for the fact that players in different positions have different body types, so speedy wide receivers weren't compared to bulkier offensive tackles. It could not assess each player's physical makeup, such as how much weight gain was muscle versus fat, one indicator of steroid use. In the most extreme case in the AP analysis, the probability that a player put on so much weight compared with other players was so rare that the odds statistically were roughly the same as an NFL quarterback throwing 12 passing touchdowns or an NFL running back rushing for 600 yards in one game.


In nearly all the rarest cases of weight gain in the AP study, players were offensive or defensive linemen, hulking giants who tower above 6-foot-3 and weigh 300 pounds or more. Four of those players interviewed by the AP said that they never used steroids and gained weight through dramatic increases in eating, up to six meals a day. Two said they were aware of other players using steroids.


"I just ate. I ate 5-6 times a day," said Clint Oldenburg, who played for Colorado State starting in 2002 and for five years in the NFL. Oldenburg's weight increased over four years from 212 to 290, including a one-year gain of 53 pounds, which he attributed to diet and two hours of weight lifting daily. "It wasn't as difficult as you think. I just ate anything."


Oldenburg told the AP he was surprised at the scope of steroid use in college football, even in Colorado State's locker room. "College performance enhancers were more prevalent than I thought," he said. "There were a lot of guys even on my team that were using." He declined to identify any of them.


The AP found more than 4,700 players — or about 7 percent of all players — who gained more than 20 pounds overall in a single year. It was common for the athletes to gain 10, 15 and up to 20 pounds in their first year under a rigorous regimen of weightlifting and diet. Others gained 25, 35 and 40 pounds in a season. In roughly 100 cases, players packed on as much 80 pounds in a single year.


In at least 11 instances, players that AP identified as packing on significant weight in college went on to fail NFL drug tests. But pro football's confidentiality rules make it impossible to know for certain which drugs were used and how many others failed tests that never became public.


What is bubbling under the surface in college football, which helps elite athletes gain unusual amounts of weight? Without access to detailed information about each player's body composition, drug testing and workout regimen, which schools do not release, it's impossible to say with certainty what's behind the trend. But Catlin has little doubt: It is steroids.


"It's not brain surgery to figure out what's going on," he said. "To me, it's very clear."


Football's most infamous steroid user was Lyle Alzado, who became a star NFL defensive end in the 1970s and '80s before he admitted to juicing his entire career. He started in college, where the 190-pound freshman gained 40 pounds in one year. It was a 21 percent jump in body mass, a tremendous gain that far exceeded what researchers have seen in controlled, short-term studies of steroid use by athletes. Alzado died of brain cancer in 1992.


The AP found more than 130 big-time college football players who showed comparable one-year gains in the past decade. Students posted such extraordinary weight gains across the country, in every conference, in nearly every school. Many of them eclipsed Alzado and gained 25, 35, even 40 percent of their body mass.


Even though testers consider rapid weight gain suspicious, in practice it doesn't result in testing. Ben Lamaak, who arrived at Iowa State in 2006, said he weighed 225 pounds in high school and 262 pounds in the summer of his freshman year on the Cyclones football team. A year later, official rosters showed the former basketball player from Cedar Rapids weighed 306, a gain of 81 pounds since high school. He graduated as a 320-pound offensive lineman and said he did it all naturally.


"I was just a young kid at that time, and I was still growing into my body," he said. "It really wasn't that hard for me to gain the weight. I had fun doing it. I love to eat. It wasn't a problem."


In addition to random drug testing, Iowa State is one of many schools that have "reasonable suspicion" testing. That means players can be tested when their behavior or physical symptoms suggest drug use.


Despite gaining 81 pounds in a year, Lamaak said he was never singled out for testing.


The associate athletics director for athletic training at Iowa State, Mark Coberley, said coaches and trainers use body composition, strength data and other factors to spot suspected cheaters. Lamaak, he said, was not suspicious because he gained a lot of "non-lean" weight.


"There are a lot of things that go into trying to identify whether guys are using performance-enhancing drugs," Coberley said. "If anybody had the answer, they'd be spotting people that do it. We keep our radar up and watch for things that are suspicious and try to protect the kids from making stupid decisions."


There's no evidence that Lamaak's weight gain was anything but natural. Gaining fat is much easier than gaining muscle. But colleges don't routinely release information on how much of the weight their players gain is muscle, as opposed to fat. Without knowing more, said Benardot, the expert at Georgia State, it's impossible to say whether large athletes were putting on suspicious amounts of muscle or simply obese, which is defined as a body mass index greater than 30.


Looking solely at the most significant weight gainers also ignores players like Bryan Maneafaiga.


In the summer of 2004, Maneafaiga was an undersized 180-pound running back trying to make the University of Hawaii football team. Twice — once in pre-season and once in the fall — he failed school drug tests, showing up positive for marijuana use. What surprised him was that the same tests turned up negative for steroids.


He'd started injecting stanozolol, a steroid, in the summer to help bulk up to a roster weight of 200 pounds. Once on the team, where he saw only limited playing time, he'd occasionally inject the milky liquid into his buttocks the day before games.


"Food and good training will only get you so far," he told the AP recently.


Maneafaiga's coach, June Jones, meanwhile, said none of his players had tested positive for doping since he took over the team in 1999. He also said publicly that steroids had been eliminated in college football: "I would say 100 percent," he told The Honolulu Advertiser in 2006.


Jones said it was news to him that one of his players had used steroids. Jones, who now coaches at Southern Methodist University, said many of his former players put on bulk working hard in the weight room. For instance, adding 70 pounds over a three- to four-year period isn't unusual, he said.


Jones said a big jump in muscle year-over-year — say 40 pounds — would be a "red light that something is not right."


Jones, a former NFL head coach, said he is unaware of any steroid use at SMU and believes the NCAA is doing a good job testing players. "I just think because the way the NCAA regulates it now that it's very hard to get around those tests," he said.


The cost of testing


While the use of drugs in professional sports is a question of fairness, use among college athletes is also important as a public policy issue. That's because most top-tier football teams are from public schools that benefit from millions of dollars each year in taxpayer subsidies. Their athletes are essentially wards of the state. Coaches and trainers — the ones who tell players how to behave, how to exercise and what to eat — are government employees.


Then there are the health risks, which include heart and liver problems and cancer.


On paper, college football has a strong drug policy. The NCAA conducts random, unannounced drug testing and the penalties for failure are severe. Players lose an entire year of eligibility after a first positive test. A second offense means permanent ineligibility from sports.


In practice, though, the NCAA's roughly 11,000 annual tests amount to just a fraction of all athletes in Division I and II schools. Exactly how many tests are conducted each year on football players is unclear because the NCAA hasn't published its data for two years. And when it did, it periodically changed the formats, making it impossible to compare one year of football to the next.


Even when players are tested by the NCAA, people involved in the process say it's easy enough to anticipate the test and develop a doping routine that results in a clean test by the time it occurs. NCAA rules say players can be notified up to two days in advance of a test, which Catlin says is plenty of time to beat a test if players have designed the right doping regimen. By comparison, Olympic athletes are given no notice.


"Everybody knows when testing is coming. They all know. And they know how to beat the test," Catlin said, adding, "Only the really dumb ones are getting caught."


Players are far more likely to be tested for drugs by their schools than by the NCAA. But while many schools have policies that give them the right to test for steroids, they often opt not to. Schools are much more focused on street drugs like cocaine and marijuana. Depending on how many tests a school orders, each steroid test can cost $100 to $200, while a simple test for street drugs might cost as little as $25.


When schools call and ask about drug testing, the first question is usually, "How much will it cost," Turpin said.


Most schools that use Drug Free Sport do not test for anabolic steroids, Turpin said. Some are worried about the cost. Others don't think they have a problem. And others believe that since the NCAA tests for steroids their money is best spent testing for street drugs, she said.


Wilfert, the NCAA official, said the possibility of steroid testing is still a deterrent, even at schools where it isn't conducted.


"Even though perhaps those institutional programs are not including steroids in all their tests, they could, and they do from time to time," she said. "So, it is a kind of deterrence."


For Catlin, one of the most frustrating things about running the UCLA testing lab was getting urine samples from schools around the country and only being asked to test for cocaine, marijuana and the like.


"Schools are very good at saying, 'Man, we're really strong on drug testing,'" he said. "And that's all they really want to be able to say and to do and to promote."


That helps explain how two school drug tests could miss Maneafaiga's steroid use. It's also possible that the random test came at an ideal time in Maneafaiga's steroid cycle.


Enforcement varies


The top steroid investigator at the U.S. Drug Enforcement Administration, Joe Rannazzisi, said he doesn't understand why schools don't invest in the same kind of testing, with the same penalties, as the NFL. The NFL has a thorough testing program for most drugs, though the league has yet to resolve a long-simmering feud with its players union about how to test for human growth hormone.


"Is it expensive? Of course, but college football makes a lot of money," he said. "Invest in the integrity of your program."


For a school to test all 85 scholarship football players for steroids twice a season would cost up to $34,000, Catlin said, plus the cost of collecting and handling the urine samples. That's about 0.2 percent of the average big-time school football budget of about $14 million. Testing all athletes in all sports would make the school's costs higher.


When schools ask Drug Free Sport for advice on their drug policies, Turpin said she recommends an immediate suspension after the first positive drug test. Otherwise, she said, "student athletes will roll the dice."


But drug use is a bigger deal at some schools than others.


At Notre Dame and Alabama, the teams that will soon compete for the national championship, players don't automatically miss games for testing positive for steroids. At Alabama, coaches have wide discretion. Notre Dame's student-athlete handbook says a player who fails a test can return to the field once the steroids are out of his system.


"If you're a strength-and-conditioning coach, if you see your kids making gains that seem a little out of line, are you going to say, 'I'm going to investigate further? I want to catch someone?'" said Anthony Roberts, an author of a book on steroids who says he has helped college football players design steroid regimens to beat drug tests.


There are schools with tough policies. The University of North Carolina kicks players off the team after a single positive test for steroids. Auburn's student-athlete handbook calls for a half-season suspension for any athlete caught using performance-enhancing drugs.


Wilfert said it's not up to the NCAA to determine whether that's fair.


"Obviously if it was our testing program, we believe that everybody should be under the same protocol and the same sanction," she said.


Fans typically have no idea that such discrepancies exist and players are left to suspect who might be cheating.


"You see a lot of guys and you know they're possibly on something because they just don't gain weight but get stronger real fast," said Orrin Thompson, a former defensive lineman at Duke. "You know they could be doing something but you really don't know for sure."


Thompson gained 85 pounds between 2001 and 2004, according to Duke rosters and Thompson himself. He said he did not use steroids and was subjected to several tests while at Duke, a school where a single positive steroid test results in a yearlong suspension.


Meanwhile at UCLA, home of the laboratory that for years set the standard for cutting-edge steroid testing, athletes can fail three drug tests before being suspended. At Bowling Green, testing is voluntary.


At the University of Maryland, students must get counseling after testing positive, but school officials are prohibited from disciplining first-time steroid users. Athletic department spokesman Matt Taylor denied that was the case and sent the AP a copy of the policy. But the policy Taylor sent included this provision: "The athletic department/coaching staff may not discipline a student-athlete for a first drug offense."


By comparison, in Kentucky and Maryland, racehorses face tougher testing and sanctions than football players at Louisville or the University of Maryland.


"If you're trying to keep a level playing field, that seems nonsensical," said Rannazzisi at the DEA. He said he was surprised to learn that what gets a free pass at one school gets players immediately suspended at another. "What message does that send? It's OK to cheat once or twice?"


Only about half the student athletes in a 2009 NCAA survey said they believed school testing deterred drug use.


As an association of colleges and universities, the NCAA could not unilaterally force schools to institute uniform testing policies and sanctions, Wilfert said.


"We can't tell them what to do, but if went through a membership process where they determined that this is what should be done, then it could happen," she said.


'Everybody around me was doing it'


Steroids are a controlled substance under federal law, but players who use them need not worry too much about prosecution. The DEA focuses on criminal operations, not individual users. When players are caught with steroids, it's often as part of a traffic stop or a local police investigation.


Jared Foster, 24, a quarterback recruited to play at the University of Mississippi, was kicked off the team in 2008 after local authorities arrested him for giving a man nandrolone, an anabolic steroid, according to court documents. Foster pleaded guilty and served jail time.


He told the AP that he doped in high school to impress college recruiters. He said he put on enough lean muscle to go from 185 pounds to 210 in about two months.


"Everybody around me was doing it," he said.


Steroids are not hard to find. A simple Internet search turns up countless online sources for performance-enhancing drugs, mostly from overseas companies.


College athletes freely post messages on steroid websites, seeking advice to beat tests and design the right schedule of administering steroids.


And steroids are still a mainstay in private, local gyms. Before the DEA shut down Alabama-based Applied Pharmacy Services as a major nationwide steroid supplier, sales records obtained by the AP show steroid shipments to bodybuilders, trainers and gym owners around the country.


Because users are rarely prosecuted, the demand is left in place after the distributor is gone.


When Joshua Hodnik was making and wholesaling illegal steroids, he had found a good retail salesman in a college quarterback named Vinnie Miroth. Miroth was playing at Saginaw Valley State, a Division II school in central Michigan, and was buying enough steroids for 25 people each month, Hodnik said.


"That's why I hired him," Hodnik said. "He bought large amounts and knew how to move it."


Miroth, who pleaded no contest in 2007 and admitted selling steroids, helped authorities build their case against Hodnik, according to court records. Now playing football in France, Miroth declined repeated AP requests for an interview.


Hodnik was released from prison this year and says he is out of the steroid business for good. He said there's no doubt that steroid use is widespread in college football.


"These guys don't start using performance-enhancing drugs when they hit the professional level," the Oklahoma City man said. "Obviously it starts well before that. And you can go back to some of the professional players who tested positive and compare their numbers to college and there is virtually no change."


Maneafaiga, the former Hawaii running back, said his steroids came from Mexico. A friend in California, who was a coach at a junior college, sent them through the mail. But Maneafaiga believes the consequences were nagging injuries. He found religion, quit the drugs and became the team's chaplain.


"God gave you everything you need," he said. "It gets in your mind. It will make you grow unnaturally. Eventually, you'll break down. It happened to me every time."


At the DEA, Rannazzisi said he has met with and conducted training for investigators and top officials in every professional sport. He's talked to Major League Baseball about the patterns his agents are seeing. He's discussed warning signs with the NFL.


He said he's offered similar training to the NCAA but never heard back. Wilfert said the NCAA staff has discussed it and hasn't decided what to do.


"We have very little communication with the NCAA or individual schools," Rannazzisi said. "They've got my card. What they've done with it? I don't know."


___


Associated Press writers Ryan Foley in Cedar Rapids, Iowa; David Brandt in Jackson, Miss.; David Skretta in Lawrence, Kan.; Don Thompson in Sacramento, Calif.;and Alexa Olesen in Shanghai, China; and researchers Susan James in New York and Monika Mathur in Washington contributed to this report.


___


Contact the Washington investigative team at DCinvestigations (at) ap.org.


Whether for athletics or age, Americans from teenagers to baby boomers are trying to get an edge by illegally using anabolic steroids and human growth hormone, despite well-documented risks. This is the first of a two-part series.


Read More..

Virginia Tech mom: Ignore gun lobby


























Newtown funerals: A community says goodbye


Newtown funerals: A community says goodbye


Newtown funerals: A community says goodbye


Newtown funerals: A community says goodbye


Newtown funerals: A community says goodbye


Newtown funerals: A community says goodbye


Newtown funerals: A community says goodbye


Newtown funerals: A community says goodbye


Newtown funerals: A community says goodbye


Newtown funerals: A community says goodbye


Newtown funerals: A community says goodbye


Newtown funerals: A community says goodbye


Newtown funerals: A community says goodbye


Newtown funerals: A community says goodbye


Newtown funerals: A community says goodbye


Newtown funerals: A community says goodbye


Newtown funerals: A community says goodbye


Newtown funerals: A community says goodbye


Newtown funerals: A community says goodbye





<<


<





1




2




3




4




5




6




7




8




9




10




11




12




13




14




15




16




17




18




19



>


>>







STORY HIGHLIGHTS


  • Lori Haas: The magnitude of the Newtown shooting shocked me

  • Haas: It reminds me of when my daughter was injured in the Virginia Tech shooting

  • She says our elected leaders have abandoned all sense of right and wrong

  • Haas: How many victims would be alive today if leaders took their responsibilities to heart?




Editor's note: Lori Haas lives in Richmond, Virginia. After her daughter Emily was shot and injured at the Virginia Tech massacre, she became involved in gun violence prevention efforts, working for the Coalition to Stop Gun Violence and Mayors Against Illegal Guns.


(CNN) -- Sitting in front of the TV on Friday, I watched in horror as the death toll climbed with each news report coming in on the mass shooting in an elementary school in Newtown, Connecticut. The magnitude of the shooting shocked me.


It also took me back to five years ago, when I received a phone call on a blustery April morning that changed my life forever. I was out shopping, and my cell phone had rung several times, but I had chosen to ignore the calls. Luckily, I answered the third call, which came in at 10:38 a.m. My daughter Emily, then a sophomore at Virginia Tech, was on the phone. She said, "Mommy, I've been shot."


Clutching the phone, my knees buckling, I tried to make sense of what I was hearing. Emily quickly handed the phone to the EMT who had triaged her and was waiting with her for an ambulance. The EMT assured me that Emily was going to be fine, that there were very seriously wounded students that needed to be transported immediately and she was waiting with Emily for the next ambulance. She also shared that the situation on campus was "very bad."



Lori Haas

Lori Haas



The world soon knew how bad it was. The incident at Virginia Tech on April 16, 2007, remains the worst mass shooting in U.S. history in terms of casualties. Thirty-two students and school staff were killed that morning by a dangerously mentally ill student with guns, including high-capacity magazines. The killer should have been prevented from purchasing firearms, but when he purchased his weapons, his mental health records were not in the FBI database against which background checks are run. He used 30-round magazines, which had been outlawed up until 2004, when Congress let the Assault Weapons Ban expire.


We were one of the lucky families -- our daughter survived, when so many others did not. Eleven of the 17 students in her classroom were killed, along with her professor. A classmate dialed 911 when they first heard the shooter, but dropped his cell phone when almost immediately, the killer burst into the classroom and began spraying bullets at everyone. Emily reached over and picked up the phone and kept the dispatcher on the phone during the entire ordeal by hiding the phone. Law enforcement repeatedly told me how brave Emily was to keep them on the line.



Law enforcement has also told me that the single most effective thing we can do to prevent gun violence would be to require all purchasers for all gun sales to undergo a background check. Then-Gov. Tim Kaine appointed a panel of experts to investigate all aspects of the massacre and report back their recommendations. Recommendation VI-2 stated, "Virginia should require background checks for all firearms sales." Sadly, that hasn't happened, and gun deaths now outpace motor vehicle deaths in my state.








America has witnessed mass shooting tragedies grow in frequency in the last five years to the point that, according to one report, there have been 16 mass shootings between February 22, 2012, and December 14, 2012, leaving over 80 dead and many injured. I can't help but ache with sorrow, anguish and concern for all those families suffering the sheer agony that I saw the families of the 32 killed at Virginia Tech suffer.


And I can't help but be angered at the cowardly behavior from our elected leaders. They have abandoned all sense of right and wrong, despite epidemic deaths from guns, and ignored their duty not only to keep our communities safe from gun violence, but to keep our children safe as well.


When I think of those killed -- over 60,000 Americans have been murdered with guns since the shooting at Virginia Tech -- I have to wonder how many might be alive today if our elected leaders had taken to heart their responsibilities.


Why is it that our elected leaders have not only ignored the pleas of survivors and family members of victims of gun violence, but those of our public safety officials -- police and law enforcement officers who put their lives on the line day in and day out -- only to listen to the gun lobby when determining public safety policy? What sense can that make when the gun lobby's sole purpose is to sell as many firearms as possible to make as much money as possible?


We have come to a time when many say the unimaginable has happened again -- the mass shooting in the Newtown school where 26 people were killed, including 20 children. It is sheer senselessness. My heart goes out with the utmost compassion to the families suffering so terribly from Friday's massacre.


For those whose loved ones have been killed, there is no real closure; there are permanent holes in their hearts. Time may lend a helping hand to healing, but their lives have been changed irrevocably. As my friend Lynnette, whose son was murdered in the Virginia Tech shooting, laments, "There is no ending to the heartache." I am brought to tears thinking of all we have seen, all we have not done and all we have let die.


Follow us on Twitter @CNNOpinion.


Join us on Facebook/CNNOpinion.


The opinions expressed in this commentary are solely those of Lori Haas.






Read More..

“Castle” star Nathan Fillion to preside over Writers Guild Awards show






LOS ANGELES (TheWrap.com) – Pretend writer Nathan Fillion will help honor real writers on February 17, when he hosts the Writers Guild Awards West Coast show, the Writers Guild of America, West said Monday.


Fillion, who plays a mystery novelist on ABC’s “Castle,” joked that he was “confused” when he was tapped for the hosting gig.






“When I first accepted the honor of hosting the Writers Guild Awards, I was confused and actually thought I was receiving one. Since I play a writer on TV, I felt perhaps someone was under the impression I deserved an award and I wasn’t about to correct them,” Fillion said. “However, now I’m in the perfect position to present myself with whichever award I choose. Who’s going to know?”


The Writers Guild Awards West Coast show will take place February 17, 2013 at the JW Marriott Los Angeles L.A. Live. The East Coast show will take place simultaneously at B.B. King Blues Club in New York City.


Writers Guild Awards executive producer Cort Casady praised Fillion’s multiple talents – along with his thriving Twitter account – in the announcement.


“Not only does he play a writer brilliantly on ‘Castle,’ but also, in addition to acting, he sings, dances, is a popular voice talent, and has a great gift for comedy,” Casady said. “And with over 1.5 million Twitter followers, Nathan brings a smart, enthusiastic audience to our celebration of writing.”


TV News Headlines – Yahoo! News





Title Post: “Castle” star Nathan Fillion to preside over Writers Guild Awards show
Rating:
100%

based on 99998 ratings.
5 user reviews.
Author: Fluser SeoLink
Thanks for visiting the blog, If any criticism and suggestions please leave a comment




Read More..